Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
Francisco Hermida‐Prado(Universidad de Oviedo), Rinath Jeselsohn(Harvard University)
Cited by 15
Related Papers
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer
|Clinical Cancer Research|2024|34
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer
|JCI Insight|2025|10
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading
|International Journal of Molecular Sciences|2024|9
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
|npj Breast Cancer|2024|4